CAROLINA LOPEZ: Open Payments
NPI 1043732100 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 15 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $16 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 3 | $316 |
| Novo Nordisk Inc | 3 | $168 |
| Amgen Inc. | 6 | $103 |
| Lilly USA, LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: DAXXIFY, Wegovy, REPATHA, ZEPBOUND, SpyGlass Discover, CAMZYOS.
Industry payments across NY — which companies pay providers there.
